Novel MCH-1 receptor antagonists are disclosed. These compounds are used in the treatment of various disorders, including obesity, anxiety, depression, non-alcoholic fatty liver disease, and psychiatric disorders. Methods of making these compounds are also described.
新型
MCH-1受体
拮抗剂被披露。这些化合物用于治疗包括肥胖、焦虑、抑郁、非
酒精性
脂肪肝病和精神障碍在内的各种疾病。制造这些化合物的方法也进行了描述。